Related Experiment Video
Updated: Mar 16, 2026

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
Published on: March 22, 2024
Tegaderm™ CHG dressing significantly improves catheter-related infection rate in hemodialysis patients
Marco Righetti1, Nicola Palmieri1, Oscar Bracchi1
1Renal Unit, Uboldo Hospital, Cernusco s/N, Milan - Italy.
Insights
Tegaderm™ chlorhexidine gluconate (CHG) dressing significantly reduced catheter-related infections in hemodialysis patients. This intervention lowered infection rates and associated healthcare costs, improving patient outcomes.
Area of Science:
- Nephrology
- Infectious Diseases
- Medical Devices
Background:
- Catheter-related infections pose a significant clinical challenge for patients undergoing maintenance hemodialysis.
- These infections negatively impact patient survival, increase hospitalization rates, and escalate healthcare costs.
- Preventive strategies are crucial to mitigate the burden of catheter-related infections in this vulnerable population.
Purpose of the Study:
- To evaluate the efficacy of Tegaderm™ chlorhexidine gluconate (CHG) dressing in reducing catheter-related infections among hemodialysis patients.
- To compare the incidence of catheter-related infections using CHG dressing versus standard dressings.
- To assess the impact of CHG dressing on catheter-related bloodstream infection rates and associated healthcare expenditures.
Main Methods:
- A prospective, randomized, cross-over study design was employed.
- The study involved two treatment periods of six months each, comparing Tegaderm™ CHG dressing with standard dressing.
- The primary outcome measured was the catheter-related infection rate, with 59 prevalent hemodialysis patients enrolled.
Main Results:
- A significant reduction in the overall catheter-related infection rate was observed, decreasing from 1.21 to 0.28 per 1000 catheter days with CHG dressing (p = 0.02).
- Catheter-related bloodstream infection rates decreased from 0.65 to 0.09 per 1000 catheter days (p = 0.05) in patients using CHG dressing.
- Estimated annual healthcare costs associated with catheter-related bloodstream infections were substantially lower with CHG dressing (EUR62,459) compared to standard dressing (EUR300,399).
Conclusions:
- This prospective study provides the first evidence that Tegaderm™ CHG dressing significantly reduces catheter-related infection rates in hemodialysis patients.
- The findings suggest that CHG dressing is an effective intervention for improving patient safety and reducing the economic burden of infections in this population.
- Implementing CHG dressings can be a valuable strategy for infection control in hemodialysis settings.
Introduction:
Catheter-related infections are an important clinical problem in maintenance hemodialysis patients. Catheter-related bloodstream infections have a negative effect on survival, hospitalization and cost of care. Tegaderm™ chlorhexidine gluconate (CHG) dressing may be useful to reduce catheter-related infection rates.
Methods:
We performed a study to assess the efficacy of Tegaderm™ CHG dressing for reducing catheter-related infections. We designed a prospective randomized cross-over study with a scheme of two treatments, Tegaderm™ CHG dressing versus standard dressing, and two periods of six months. Catheter-related infection rate was the primary outcome. We enrolled 59 prevalent hemodialysis patients.
Results:
Catheter-related infection rate per 1000 catheter days was reduced from 1.21 in patients using standard dressing to 0.28 in patients with Tegaderm™ CHG dressing (p = 0.02). Catheter-related bloodstream infection rate per 1000 catheter days was equal to 0.09 in patients with Tegaderm™ CHG dressing versus 0.65 in patients with standard dressing (p = 0.05). Annual total healthcare costs for catheter-related bloodstream infections were estimated equal to EUR62,459 versus EUR300,399, respectively, for patients with Tegaderm™ CHG versus standard dressing.
Conclusions:
This is the first prospective study to show that Tegaderm™ CHG dressing significantly reduces catheter-related infection rates in hemodialysis patients.
Related Concept Videos
Endocarditis IV: Nursing Management
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Hemodialysis III: Nursing Management
Continuous Renal Replacement Therapy
Peritoneal Dialysis III: Nursing Management

